Current Journal of Neurology

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Peer Review Process

Journal Metrics

News

Publication Ethics and Malpractice Statement

Browse Keyword Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ALL

A

  • Adipose tissue Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

  • Adverse effects Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports [Volume 22, Issue 2, 2023, Pages 115-136]

  • Alcohol Abuse Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

  • Alternate Dose Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review [Volume 22, Issue 2, 2023, Pages 110-114]

  • Alzheimer's Disease Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals [Volume 22, Issue 4, 2023, Pages 221-230]

  • Aneurysmal Subarachnoid Hemorrhage The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Antiepileptic Drug Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

  • Anxiety Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Aquaporins Eculizumab in the treatment of neuromyelitis optica spectrum disorder [Volume 22, Issue 2, 2023, Pages 140-143]

  • AstraZeneca Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • Atomoxetine Hydrochloride The effect of atomoxetine on cognitive function in patients with multiple sclerosis [Volume 22, Issue 3, 2023, Pages 149-154]

B

  • Body Mass Index The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

C

  • Carbamazepine Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

  • Cardiovascular Disease The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Carnitine The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study [Volume 22, Issue 1, 2023, Pages 30-34]

  • Case-Control Studies Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs [Volume 22, Issue 1, 2023, Pages 44-49]

  • Case-Control Studies Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • Central Nervous System Viral Diseases Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication [Volume 22, Issue 2, 2023, Pages 137-139]

  • Cerebrovascular Circulation Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals [Volume 22, Issue 4, 2023, Pages 221-230]

  • Cerebrovascular Disorders Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]

  • Cerebrovascular Disorders The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Challenge Challenges of patients with multiple sclerosis in receiving health care services in Iran [Volume 22, Issue 1, 2023, Pages 16-22]

  • Chest Computed Tomography Scan Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy Prognosis and outcome in patients with chronic inflammatory demyelinating polyradiculoneuropathy in a tertiary center in Oman [Volume 22, Issue 3, 2023, Pages 144-148]

  • Chronic Pain Chronic pain among Lebanese individuals with spinal cord injury: Pain interference and impact on quality of life [Volume 22, Issue 4, 2023, Pages 238-248]

  • Cigarette Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

  • Clinical Characteristics Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]

  • Cognition The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature [Volume 22, Issue 1, 2023, Pages 50-57]

  • Cognitive Disorders The effect of atomoxetine on cognitive function in patients with multiple sclerosis [Volume 22, Issue 3, 2023, Pages 149-154]

  • Cognitive Dysfunction Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Cognitive Dysfunction Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals [Volume 22, Issue 4, 2023, Pages 221-230]

  • Computed Tomography Scan Characteristic brain computed tomography of infective endocarditis after thrombolysis for ischemic stroke: A clinical note [Volume 22, Issue 3, 2023, Pages 201-202]

  • Covid-19 The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

  • Covid-19 Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study [Volume 22, Issue 2, 2023, Pages 82-86]

  • Covid-19 Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

  • Covid-19 Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]

  • Covid-19 Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Covid-19 Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • COVID-19 Vaccines Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

D

  • Daily Dose Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review [Volume 22, Issue 2, 2023, Pages 110-114]

  • Decision Support Techniques A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting [Volume 22, Issue 1, 2023, Pages 58-62]

  • Deglutition The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Delayed Diagnosis Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models [Volume 22, Issue 2, 2023, Pages 65-71]

  • Dietary Pattern Association of dietary patterns with migraine: A matched case-control study [Volume 22, Issue 2, 2023, Pages 87-95]

  • Disability Evaluation Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models [Volume 22, Issue 2, 2023, Pages 65-71]

  • Drug Eruptions Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

  • Duchenne Muscular Dystrophy On genotype-phenotype relationship of dystrophinopathies among Iranian population [Volume 22, Issue 4, 2023, Pages 231-237]

  • Dysphagia The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Dystrophin On genotype-phenotype relationship of dystrophinopathies among Iranian population [Volume 22, Issue 4, 2023, Pages 231-237]

E

  • Eculizumab Eculizumab in the treatment of neuromyelitis optica spectrum disorder [Volume 22, Issue 2, 2023, Pages 140-143]

  • Electrical Stimulation The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Electrodiagnostic Study An assessment of Martin-Gruber anastomosis discrepancies between healthy individuals and patients with carpal tunnel syndrome in motor nerve conduction studies [Volume 22, Issue 3, 2023, Pages 179-187]

  • Emergency Medical Services A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting [Volume 22, Issue 1, 2023, Pages 58-62]

  • Encephalitis Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication [Volume 22, Issue 2, 2023, Pages 137-139]

  • Endocarditis Characteristic brain computed tomography of infective endocarditis after thrombolysis for ischemic stroke: A clinical note [Volume 22, Issue 3, 2023, Pages 201-202]

  • Enophthalmos Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

  • Epidemiology Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran [Volume 22, Issue 2, 2023, Pages 103-109]

  • Epidemiology An assessment of Martin-Gruber anastomosis discrepancies between healthy individuals and patients with carpal tunnel syndrome in motor nerve conduction studies [Volume 22, Issue 3, 2023, Pages 179-187]

  • Epilepsy Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

  • Expanded Disability Status Scale The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study [Volume 22, Issue 1, 2023, Pages 30-34]

F

  • Fatigue The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study [Volume 22, Issue 1, 2023, Pages 30-34]

  • Fingolimod Hydrochloride Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review [Volume 22, Issue 2, 2023, Pages 110-114]

G

  • Genetic Polymorphism Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs [Volume 22, Issue 1, 2023, Pages 44-49]

  • Genotype On genotype-phenotype relationship of dystrophinopathies among Iranian population [Volume 22, Issue 4, 2023, Pages 231-237]

  • Glatiramer acetate Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports [Volume 22, Issue 2, 2023, Pages 115-136]

  • Guillain-Barre Syndrome Injudicious use of cranio-spinal imaging in Guillain-Barré syndrome in a low resource country [Volume 22, Issue 4, 2023, Pages 261-264]

H

  • Health Services Challenges of patients with multiple sclerosis in receiving health care services in Iran [Volume 22, Issue 1, 2023, Pages 16-22]

  • Horner syndrome Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

I

  • Immunosuppressive Therapy Eculizumab in the treatment of neuromyelitis optica spectrum disorder [Volume 22, Issue 2, 2023, Pages 140-143]

  • Immunosuppressive Therapy Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication [Volume 22, Issue 2, 2023, Pages 137-139]

  • Inborn Errors of Metabolism A case of type II fucosidosis-diagnosed with neuroradiological and dysmorphological findings [Volume 22, Issue 4, 2023, Pages 265-267]

  • India Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs [Volume 22, Issue 1, 2023, Pages 44-49]

  • Induced Hypertension The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Infections Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Interferon beta-1a Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports [Volume 22, Issue 2, 2023, Pages 115-136]

  • Intracranial Hemorrhages Characteristic brain computed tomography of infective endocarditis after thrombolysis for ischemic stroke: A clinical note [Volume 22, Issue 3, 2023, Pages 201-202]

  • Intracranial Neoplasms Stealthily growing large sinonasal lymphoma with intracranial extension [Volume 22, Issue 3, 2023, Pages 203-203]

  • Iran Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Iran The prevalence of multiple sclerosis in Tehran, Iran, in 2020 [Volume 22, Issue 1, 2023, Pages 63-64]

  • Iran Challenges of patients with multiple sclerosis in receiving health care services in Iran [Volume 22, Issue 1, 2023, Pages 16-22]

  • Iran Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models [Volume 22, Issue 2, 2023, Pages 65-71]

  • Iran Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran [Volume 22, Issue 2, 2023, Pages 103-109]

  • Iran Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics [Volume 22, Issue 4, 2023, Pages 204-209]

  • Iran On genotype-phenotype relationship of dystrophinopathies among Iranian population [Volume 22, Issue 4, 2023, Pages 231-237]

  • Ischemic Stroke Characteristic brain computed tomography of infective endocarditis after thrombolysis for ischemic stroke: A clinical note [Volume 22, Issue 3, 2023, Pages 201-202]

J

  • JC virus Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication [Volume 22, Issue 2, 2023, Pages 137-139]

L

  • Lebanon Chronic pain among Lebanese individuals with spinal cord injury: Pain interference and impact on quality of life [Volume 22, Issue 4, 2023, Pages 238-248]

  • Lymphoma Stealthily growing large sinonasal lymphoma with intracranial extension [Volume 22, Issue 3, 2023, Pages 203-203]

  • Lysosomal Storage Diseases A case of type II fucosidosis-diagnosed with neuroradiological and dysmorphological findings [Volume 22, Issue 4, 2023, Pages 265-267]

M

  • Magnetic Resonance Imaging A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting [Volume 22, Issue 1, 2023, Pages 58-62]

  • Magnetic Resonance Imaging Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication [Volume 22, Issue 2, 2023, Pages 137-139]

  • Magnetic Resonance Imaging Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]

  • Magnetic Resonance Imaging A case of type II fucosidosis-diagnosed with neuroradiological and dysmorphological findings [Volume 22, Issue 4, 2023, Pages 265-267]

  • Median Nerve An assessment of Martin-Gruber anastomosis discrepancies between healthy individuals and patients with carpal tunnel syndrome in motor nerve conduction studies [Volume 22, Issue 3, 2023, Pages 179-187]

  • Medical Informatics Applications Stability monitoring of patients with myasthenia gravis using a mobile-based application [Volume 22, Issue 1, 2023, Pages 35-43]

  • Migraine Disorders Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs [Volume 22, Issue 1, 2023, Pages 44-49]

  • Migraine Disorders Association of dietary patterns with migraine: A matched case-control study [Volume 22, Issue 2, 2023, Pages 87-95]

  • Mobile Applications Stability monitoring of patients with myasthenia gravis using a mobile-based application [Volume 22, Issue 1, 2023, Pages 35-43]

  • Mobile Health Stability monitoring of patients with myasthenia gravis using a mobile-based application [Volume 22, Issue 1, 2023, Pages 35-43]

  • Monitoring Stability monitoring of patients with myasthenia gravis using a mobile-based application [Volume 22, Issue 1, 2023, Pages 35-43]

  • Mucormycosis Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • Multiple Cranial Nerves Stealthily growing large sinonasal lymphoma with intracranial extension [Volume 22, Issue 3, 2023, Pages 203-203]

  • Multiple Sclerosis Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Multiple Sclerosis The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature [Volume 22, Issue 1, 2023, Pages 50-57]

  • Multiple Sclerosis The prevalence of multiple sclerosis in Tehran, Iran, in 2020 [Volume 22, Issue 1, 2023, Pages 63-64]

  • Multiple Sclerosis Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • Multiple Sclerosis Challenges of patients with multiple sclerosis in receiving health care services in Iran [Volume 22, Issue 1, 2023, Pages 16-22]

  • Multiple Sclerosis The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

  • Multiple Sclerosis The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study [Volume 22, Issue 1, 2023, Pages 30-34]

  • Multiple Sclerosis Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review [Volume 22, Issue 2, 2023, Pages 110-114]

  • Multiple Sclerosis Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study [Volume 22, Issue 2, 2023, Pages 82-86]

  • Multiple Sclerosis Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models [Volume 22, Issue 2, 2023, Pages 65-71]

  • Multiple Sclerosis Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Multiple Sclerosis Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran [Volume 22, Issue 2, 2023, Pages 103-109]

  • Multiple Sclerosis Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports [Volume 22, Issue 2, 2023, Pages 115-136]

  • Multiple Sclerosis The effect of atomoxetine on cognitive function in patients with multiple sclerosis [Volume 22, Issue 3, 2023, Pages 149-154]

  • Multiple Sclerosis Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics [Volume 22, Issue 4, 2023, Pages 204-209]

  • Multiple Sclerosis Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Myasthenia Gravis Stability monitoring of patients with myasthenia gravis using a mobile-based application [Volume 22, Issue 1, 2023, Pages 35-43]

N

  • Nerve Conduction Studies Prognosis and outcome in patients with chronic inflammatory demyelinating polyradiculoneuropathy in a tertiary center in Oman [Volume 22, Issue 3, 2023, Pages 144-148]

  • Neurofilament Light Chain Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals [Volume 22, Issue 4, 2023, Pages 221-230]

  • Neuroimaging Characteristic brain computed tomography of infective endocarditis after thrombolysis for ischemic stroke: A clinical note [Volume 22, Issue 3, 2023, Pages 201-202]

  • Neuroimaging Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

  • Neuroimaging Injudicious use of cranio-spinal imaging in Guillain-Barré syndrome in a low resource country [Volume 22, Issue 4, 2023, Pages 261-264]

  • Neurological Manifestations Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • Neurology A case of type II fucosidosis-diagnosed with neuroradiological and dysmorphological findings [Volume 22, Issue 4, 2023, Pages 265-267]

  • Neuromuscular Junction Diseases Stability monitoring of patients with myasthenia gravis using a mobile-based application [Volume 22, Issue 1, 2023, Pages 35-43]

  • Neuromyelitis Optica Eculizumab in the treatment of neuromyelitis optica spectrum disorder [Volume 22, Issue 2, 2023, Pages 140-143]

  • Nomograms A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting [Volume 22, Issue 1, 2023, Pages 58-62]

  • Norepinephrine Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

O

  • Obesity The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

  • Obsessive-Compulsive Disorder Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics [Volume 22, Issue 4, 2023, Pages 204-209]

  • Olfactory Olfactory dysfunction in patients with Parkinson's disease: A systematic review and meta-analysis [Volume 22, Issue 4, 2023, Pages 249-254]

  • Oman Prognosis and outcome in patients with chronic inflammatory demyelinating polyradiculoneuropathy in a tertiary center in Oman [Volume 22, Issue 3, 2023, Pages 144-148]

P

  • Pain Interference Chronic pain among Lebanese individuals with spinal cord injury: Pain interference and impact on quality of life [Volume 22, Issue 4, 2023, Pages 238-248]

  • Parkinson Disease Olfactory dysfunction in patients with Parkinson's disease: A systematic review and meta-analysis [Volume 22, Issue 4, 2023, Pages 249-254]

  • Patients Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics [Volume 22, Issue 4, 2023, Pages 204-209]

  • Pediatrics A case of type II fucosidosis-diagnosed with neuroradiological and dysmorphological findings [Volume 22, Issue 4, 2023, Pages 265-267]

  • Peripheral Neuropathies Injudicious use of cranio-spinal imaging in Guillain-Barré syndrome in a low resource country [Volume 22, Issue 4, 2023, Pages 261-264]

  • Phenotype On genotype-phenotype relationship of dystrophinopathies among Iranian population [Volume 22, Issue 4, 2023, Pages 231-237]

  • Pneumonia The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Postoperative Complications Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Prevalence The prevalence of multiple sclerosis in Tehran, Iran, in 2020 [Volume 22, Issue 1, 2023, Pages 63-64]

  • Prevalence Olfactory dysfunction in patients with Parkinson's disease: A systematic review and meta-analysis [Volume 22, Issue 4, 2023, Pages 249-254]

  • Primary Progressive Multiple Sclerosis Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

  • Principal Component Analysis Association of dietary patterns with migraine: A matched case-control study [Volume 22, Issue 2, 2023, Pages 87-95]

  • Prognosis Prognosis and outcome in patients with chronic inflammatory demyelinating polyradiculoneuropathy in a tertiary center in Oman [Volume 22, Issue 3, 2023, Pages 144-148]

  • Progressive multifocal leukoencephalopathy Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication [Volume 22, Issue 2, 2023, Pages 137-139]

  • Prudent Diet Association of dietary patterns with migraine: A matched case-control study [Volume 22, Issue 2, 2023, Pages 87-95]

Q

  • Quality of Life Challenges of patients with multiple sclerosis in receiving health care services in Iran [Volume 22, Issue 1, 2023, Pages 16-22]

  • Quality of Life Chronic pain among Lebanese individuals with spinal cord injury: Pain interference and impact on quality of life [Volume 22, Issue 4, 2023, Pages 238-248]

R

  • Randomized Clinical Trial The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Rash Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

  • Recurrence Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study [Volume 22, Issue 2, 2023, Pages 82-86]

  • Resilience Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Retina The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature [Volume 22, Issue 1, 2023, Pages 50-57]

  • Review Olfactory dysfunction in patients with Parkinson's disease: A systematic review and meta-analysis [Volume 22, Issue 4, 2023, Pages 249-254]

  • Risk The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

  • Risk Factors Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

S

  • SARS-CoV-2 Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • SARS-CoV-2 Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • SERT Gene Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs [Volume 22, Issue 1, 2023, Pages 44-49]

  • Sinonasal Tumor Stealthily growing large sinonasal lymphoma with intracranial extension [Volume 22, Issue 3, 2023, Pages 203-203]

  • Sinopharm Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • Social Support Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Spinal Cord Injuries Chronic pain among Lebanese individuals with spinal cord injury: Pain interference and impact on quality of life [Volume 22, Issue 4, 2023, Pages 238-248]

  • Stroke A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting [Volume 22, Issue 1, 2023, Pages 58-62]

  • Stroke Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

  • Stroke Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]

  • Stroke The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Substance-Related Disorders Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

  • Surgery Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Sympathetic Nervous System Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

  • Symptom Assessment The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

  • Systematic Review Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports [Volume 22, Issue 2, 2023, Pages 115-136]

  • Systemic Lupus Erythematosus Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication [Volume 22, Issue 2, 2023, Pages 137-139]

T

  • Thrombolytic Therapy Characteristic brain computed tomography of infective endocarditis after thrombolysis for ischemic stroke: A clinical note [Volume 22, Issue 3, 2023, Pages 201-202]

  • Tissue Plasminogen Activator Characteristic brain computed tomography of infective endocarditis after thrombolysis for ischemic stroke: A clinical note [Volume 22, Issue 3, 2023, Pages 201-202]

  • Transcranial Direct Current Stimulation The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Treatment Outcome Prognosis and outcome in patients with chronic inflammatory demyelinating polyradiculoneuropathy in a tertiary center in Oman [Volume 22, Issue 3, 2023, Pages 144-148]

U

  • Ulnar Nerve An assessment of Martin-Gruber anastomosis discrepancies between healthy individuals and patients with carpal tunnel syndrome in motor nerve conduction studies [Volume 22, Issue 3, 2023, Pages 179-187]

V

  • Vaccination Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • Vision Loss Stealthily growing large sinonasal lymphoma with intracranial extension [Volume 22, Issue 3, 2023, Pages 203-203]

W

  • Waterpipe Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

  • Western Diet Association of dietary patterns with migraine: A matched case-control study [Volume 22, Issue 2, 2023, Pages 87-95]

  • White Matter Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]